Related Experiment Video
Updated: Aug 29, 2025
11:29
Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain
Published on: October 3, 2012
10.8K
Oligomeropathies, inflammation and prion protein binding
Gianluigi Forloni1, Pietro La Vitola1, Claudia Balducci1
1Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Frontiers in Neuroscience
|September 9, 2022
Summary
Misfolded protein oligomers drive neurodegenerative diseases like Alzheimer's and Parkinson's. Controlling inflammation and exploring treatments like doxycycline show therapeutic promise for these oligomeropathies.
Area of Science:
- Neuroscience
- Pathology
- Pharmacology
Background:
- Oligomers, small soluble aggregates of misfolded proteins, are central to neurodegenerative disease pathogenesis.
- The term 'oligomeropathies' defines the shared mechanism in protein misfolding diseases such as Alzheimer's, Parkinson's, and prion diseases.
- Clinical evidence supports the role of oligomers in diseases affecting cognitive behavior and neuronal function.
Purpose of the Study:
- To investigate the distinct biological consequences of beta-amyloid and alpha-synuclein oligomers.
- To explore the role of cellular prion protein in oligomer-induced pathogenesis.
- To evaluate the therapeutic potential of doxycycline in managing neurodegenerative disorders.
Main Methods:
- Intraventricular administration of synthetic beta-amyloid and alpha-synuclein oligomers in experimental models.
- Assessment of cognitive behavior, neuronal dysfunction, and inflammatory reactions.
- Analysis of doxycycline's anti-amyloidogenic and anti-inflammatory effects.
Main Results:
- Both beta-amyloid and alpha-synuclein oligomers induced cognitive deficits, neuronal dysfunction, and neuroinflammation via distinct mechanisms.
- The proposed mediatory role of cellular prion protein was not confirmed under these experimental conditions.
- Oligomer-induced inflammation significantly impacts neuronal dysfunction, highlighting its early importance.
Conclusions:
- Protein oligomers are key players in neurodegenerative diseases, with distinct pathogenic pathways.
- Inflammation is an early and critical factor in neurodegeneration, influenced by oligomer species.
- Doxycycline exhibits potential as a therapeutic agent due to its anti-amyloidogenic and anti-inflammatory properties.
Related Concept Videos
03:03Amyloid Fibrils
9.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.7K
01:05Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
01:29Protein Folding Quality Check in the RER
3.8K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.8K
01:22Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
01:24Oligosaccharide Assembly
3.0K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
3.0K
00:49Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K